Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals Plc announced that between July 13 and July 17, 2026, it repurchased 492,000 ordinary shares as part of its $250 million share buyback program. The company intends to cancel these shares, and following this, the total number of issued shares will be 211,204,519, with the total voting rights remaining the same. Since the program's inception on February 26, 2026, Hikma has bought back a total of 10,681,934 ordinary shares for £146,611,496.31.

Disclaimer*

UK 100